EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria

Şengül Beyaz, Serkan Belkaya, Nida Öztop

Allergologia et Immunopathologia · 2023

DOI: 10.15586/aei.v51i4.894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2023. Verfasst von Şengül Beyaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Immunology and Allergic Diseases, Ankara Bilkent City Hospital, Ankara, Turkey; sengulbeyaz@gmail.com. Hauptthemen laut MEDLINE: Urticaria, Chronic Urticaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pentraxin-3 (PTX3) is a soluble long pentraxin molecule that regulates inflammatory responses. This study aimed to determine the plasma levels of plasma PTX-3 as an inflammation marker in chronic spontaneous urticaria (CSU) and whether the PTX3 levels correlate with disease activity and other clinical parameters, including acute phase reactants and biomarkers.

Methods

The study included 70 CSU patients and 30 healthy controls. Plasma PTX3 levels were measured by ELISA. CSU disease activity was evaluated with the urticaria activity score summed over 7 days. Complete blood count, C-reactive protein (CRP), transaminases, total IgE, antinuclear antibody, anti-thyroid peroxidase, anti-thyroglobulin, and D-dimer levels were recorded.

Results

Of the 70 patients, 52 (74.3%) were female, with a mean age of 37.51 ± 11.80 years. Disease activity was severe in 43, moderate in 15, and mild in 12 patients. Mean PTX3 levels were elevated in CSU patients compared to healthy controls (0.81 vs. 0.55 ng/mL, p = 0.031). The mean CRP levels were higher in patients than in the controls (4.26 vs. 1.57 mg/L, p = 0.023). Patients also had higher D-dimer levels than the controls (5.96 vs. 0.59 mg/L, p < 0.001). A significant positive correlation was found between PTX3 and CRP levels (r = 0.508, p < 0.001) and between D-dimer levels and UAS7 (r = 0.338, p = 0.004) and CRP (r = 0.213, p = 0.034) levels. A multivariable stepwise regression analysis showed that the one-unit increase in the CRP level increased to 38.19 units in the PTX3 level (95% confidence interval [17.40–58.98], p < 0.001).

Conclusion

Circulating levels of CRP and PTX3, two members of the pentraxin family, are significantly correlated and elevated in CSU patients with increasing disease activity, indicating their utility as inflammatory markers in CSU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UrticariaChronic UrticariaHumansFemaleAdultMiddle AgedMaleC-Reactive ProteinChronic DiseaseBiomarkers

Stichwörter der Autor:innen

C-reactive proteinD-dimerchronic spontaneous urticariapentraxin-3urticaria activity score

Substanzen

C-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • Clinic of Immunology and Allergic Diseases, Ankara Bilkent City Hospital, Ankara, Turkey; sengulbeyaz@gmail.com.
  • Department of Molecular Biology and Genetics, Faculty of Science, İhsan Doğramacı Bilkent University, Ankara, Turkey.
  • Clinic of Immunology and Allergic Diseases, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey.

Zitieren

APA

Beyaz, Ş., Belkaya, S., & Öztop, N. (2023). Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v51i4.894

Vancouver

Beyaz Ş, Belkaya S, Öztop N. Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria. Allergologia et Immunopathologia. 2023. doi:10.15586/aei.v51i4.894

BibTeX
@article{Beyaz2023,
  author = {Beyaz, Şengül and Belkaya, Serkan and Öztop, Nida},
  title = {Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria},
  journal = {Allergologia et Immunopathologia},
  year = {2023},
  doi = {10.15586/aei.v51i4.894}
}
Kostenlos starten →